Concepts (61)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Carcinoma, Non-Small-Cell Lung | 5 | 2016 | 351 | 0.420 |
Why?
|
| Lung Neoplasms | 5 | 2016 | 1662 | 0.270 |
Why?
|
| Allelic Imbalance | 1 | 2016 | 11 | 0.130 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 2016 | 674 | 0.110 |
Why?
|
| Proto-Oncogene Protein c-ets-2 | 1 | 2013 | 8 | 0.110 |
Why?
|
| Proto-Oncogene Proteins c-met | 1 | 2013 | 24 | 0.110 |
Why?
|
| Oncogene Proteins | 1 | 2014 | 136 | 0.110 |
Why?
|
| Bronchi | 1 | 2012 | 98 | 0.100 |
Why?
|
| Respiratory Mucosa | 1 | 2012 | 91 | 0.100 |
Why?
|
| Adenocarcinoma | 2 | 2016 | 1023 | 0.090 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2014 | 1894 | 0.090 |
Why?
|
| Smoking | 2 | 2014 | 1047 | 0.090 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2012 | 293 | 0.080 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2016 | 1148 | 0.080 |
Why?
|
| Genome, Human | 1 | 2016 | 1273 | 0.080 |
Why?
|
| Gene Expression Profiling | 2 | 2013 | 1708 | 0.080 |
Why?
|
| Transcriptome | 1 | 2014 | 953 | 0.070 |
Why?
|
| Membrane Proteins | 1 | 2014 | 1530 | 0.060 |
Why?
|
| Neoplasm Staging | 3 | 2016 | 1279 | 0.060 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2012 | 601 | 0.060 |
Why?
|
| Prognosis | 2 | 2016 | 4633 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 1 | 2016 | 1065 | 0.030 |
Why?
|
| Receptors, Vasoactive Intestinal Polypeptide, Type I | 1 | 2014 | 2 | 0.030 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2014 | 107 | 0.030 |
Why?
|
| Hepatocyte Growth Factor | 1 | 2013 | 29 | 0.030 |
Why?
|
| Microarray Analysis | 1 | 2014 | 229 | 0.030 |
Why?
|
| Chromosome Aberrations | 1 | 2016 | 616 | 0.030 |
Why?
|
| Immunoenzyme Techniques | 1 | 2012 | 258 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2013 | 358 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2013 | 398 | 0.020 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2012 | 145 | 0.020 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2014 | 503 | 0.020 |
Why?
|
| Neoplasm Grading | 1 | 2012 | 274 | 0.020 |
Why?
|
| Bronchoscopy | 1 | 2012 | 152 | 0.020 |
Why?
|
| Neoplasm Invasiveness | 1 | 2013 | 621 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2014 | 867 | 0.020 |
Why?
|
| Lung Injury | 1 | 2012 | 124 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2016 | 882 | 0.020 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2012 | 336 | 0.020 |
Why?
|
| Cell Movement | 1 | 2013 | 847 | 0.020 |
Why?
|
| Recurrence | 1 | 2013 | 1420 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2012 | 1016 | 0.020 |
Why?
|
| Pneumonia | 1 | 2012 | 323 | 0.020 |
Why?
|
| Middle Aged | 3 | 2014 | 26900 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2016 | 3296 | 0.020 |
Why?
|
| Biopsy | 1 | 2012 | 1237 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2012 | 1695 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2012 | 1627 | 0.020 |
Why?
|
| Lung | 1 | 2016 | 1492 | 0.020 |
Why?
|
| Biomarkers, Tumor | 1 | 2016 | 1495 | 0.020 |
Why?
|
| Genomics | 1 | 2016 | 1502 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2016 | 5166 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2013 | 3350 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2013 | 2309 | 0.020 |
Why?
|
| Humans | 5 | 2016 | 124955 | 0.020 |
Why?
|
| Aged | 2 | 2014 | 19840 | 0.020 |
Why?
|
| Male | 3 | 2014 | 61419 | 0.010 |
Why?
|
| Female | 3 | 2014 | 66678 | 0.010 |
Why?
|
| Time Factors | 1 | 2012 | 6328 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2013 | 4530 | 0.010 |
Why?
|
| Adult | 1 | 2014 | 29586 | 0.010 |
Why?
|